In summary, we found that TREM-1 is highly expressed on myeloid cells in tumor-bearing mice and in patients with RCC and that TREM-2 is co-expressed with TREM-1 in MDSC and TAM. This evidence concerns the gene TREM2 and renal cell carcinoma.